A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer

NCT01709734 · clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
126
Enrollment
INDUSTRY
Sponsor class

Stopped Study was terminated prematurely in all investigational study centers upon recommendation from the study's Data Monitoring Committee (DMC). Study was stopped due to lack of efficacy.

Conditions

Interventions

Sponsor

LTN PHARMACEUTICALS, INC.